Holmusk, a Singapore-headquartered digital health and data analytics company with a global presence, recently announced closing of $9.75 million in Pre-Series A financing. The financing round included funding from Heritas Venture Fund as well as participation from new and existing investors. The funds allow Holmusk to expand its footprint in USA and Europe.

Holmusk leverages technology and data science to accelerate research and improve outcomes for people with chronic diseases and behavioral health disorders. Partnering with Pharma and healthcare providers, Holmusk informs predictive algorithms and provides actionable insights for personalized medicine through its proprietary modelling platform. Alongside this, it has an innovative digital health platform for patient engagement.

Holmusk is also expanding its assets in behavioral health.  Having acquired MindLinc, a behavioral health EHR, it now holds one of the largest behavioral health databases in the world. Combining system dynamics with deep learning neural networks and quantitative systems pharmacology, Holmusk is developing MindLinc 2.0 which will include predictive disease models based on longitudinal patient data.